Search Results - "Goody, Rebecca"

Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy (SABR) Treatment in Hepatocellular Carcinoma (HCC): Preliminary Assessment by Gravell, Rachel, Frood, Russell, Littlejohns, Anna, Casanova, Nathalie, Goody, Rebecca, Podesta, Christine, Albazaz, Raneem, Scarsbrook, Andrew

“…The study purpose was to develop a machine learning (ML)-based predictive model for event-free survival (EFS) in patients with hepatocellular carcinoma (HCC)…”
Get full text

Phase I trial of radiation therapy and sorafenib in unresectable liver metastases by Goody, Rebecca B, Brade, Anthony M, Wang, Lisa, Craig, Tim, Brierley, James, Dinniwell, Robert, Wong, Rebecca K.S, Cho, Charles, Kim, John, Kassam, Zahra, Ringash, Jolie, Knox, Jennifer J, Dawson, Laura A

“…Abstract Background and purpose To determine maximum tolerated dose (MTD) and toxicities of sorafenib combined with stereotactic radiotherapy (SBRT) or whole…”
Get full text

Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume by Scarsbrook, Andrew, Ward, Gillian, Murray, Patrick, Goody, Rebecca, Marshall, Karen, McDermott, Garry, Prestwich, Robin, Radhakrishna, Ganesh

“…To assess the feasibility and potential impact on target delineation of respiratory-gated (4D) contrast-enhanced Fluorine fluorodeoxyglucose (FDG) positron…”
Get full text

Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric Cancer by Goody, Rebecca B., MBChB, MacKay, Helen, MBChB, MD, Pitcher, Bethany, MSc, Oza, Amit, MD, Siu, Lillian L., MD, Kim, John, MD, Wong, Rebecca K.S., MBChB, MSc, Chen, Eric, MD, Swallow, Carol, MD, Knox, Jennifer, MD, Kassam, Zahra, MBBS, MSc, Cummings, Bernard, MBChB, Feld, Ron, MD, Hedley, David, MD, Liu, Geoffrey, MD, Krzyzanowska, Monika K., MD, Dinniwell, Robert, MD, MSc, Brade, Anthony M., MD, CM, PhD, Dawson, Laura A., MD, Pintilie, Melania, MSc, Ringash, Jolie, MD, MSc

“…Purpose Locoregional recurrence is common after surgery for gastric cancer. Adjuvant therapy improves outcomes but with toxicity. This phase 1/2 study…”
Get full text

Metastatic Melanoma: A Regional Review and Future Directions by Khan, Khurum H, Goody, Rebecca B, Hameed, Hassan, Jalil, Awais, Coyle, Vicky M, McAleer, James JA

“…Aims and background The incidence of malignant melanoma has risen steadily over recent decades. NCI data from 2005–2007 have suggested that 1.93% of…”
Get full text

Occult lung malignancy presenting with finger pain: a case report by Embley, Matthew A, Goody, Rebecca B, Mughrabi, Mahmood

“…Lung cancer is currently one of the most common malignancies in the world. Early detection is an important prognostic factor. Unfortunately, initial symptoms…”
Get full text

Combination treatment of HCC with SBRT and immune checkpoint inhibition by Podesta, Christine, Kayani, Mahaz, Goody, Rebecca, Samson, Adel

“…The treatment of unresectable or metastatic HCC has been significantly advanced in recent years by developments in both radiotherapy and systemic cancer…”
Get full text

Can Concurrent Chemoradiotherapy Add Meaningful Benefit in Addition to Induction Chemotherapy in the Management of Borderline Resectable and Locally Advanced Pancreatic Cancer?: A Systematic Review by Saha, Animesh, Wadsley, Jonathan, Sirohi, Bhawna, Goody, Rebecca, Anthony, Alan, Perumal, Karthikeyan, Ulahanan, Danny, Collinson, Fiona

“…The role of concomitant chemoradiotherapy or radiotherapy (RT) after induction chemotherapy (IC) in borderline resectable and locally advanced pancreatic…”
Get full text

Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy : Preliminary Assessment by Gravell, Rachel, Frood, Russell, Littlejohns, Anna, Casanova, Nathalie, Goody, Rebecca, Podesta, Christine, Albazaz, Raneem, Scarsbrook, Andrew

“…Background: The study purpose was to develop a machine learning (ML)-based predictive model for event-free survival (EFS) in patients with hepatocellular…”
Get full text

Conformal 3D computed tomography planned endoluminal brachytherapy for the local control of esophageal cancer by Jones, Christopher M., Lyles, Annabel, Bownes, Peter, Goody, Rebecca, Hingorani, Mohan, Joseph, Eldho, Radhakrishna, Ganesh

“…PURPOSETo outline the toxicity, tolerability, and efficacy of a 3D conformal computed tomography planned endoluminal brachytherapy (ELBT) treatment for…”
Get full text

The Impact of Disease Progression on Health-Related Quality of Life Outcomes in Patients With Oligometastatic Disease at 12 Months Post Stereotactic Body Radiation Therapy by Barry, Aisling S., Bezjak, Andrea, Helou, Joelle, Goodwin, Pamela, Kiss, Alex, Ringash, Jolie, Goody, Rebecca, Munoz-Schuffenegger, Pablo, Lindsay, Patricia E., Pellizzari, Alana, Ponichtera, Jan, Liu, Zhi Hui, Wong, Rebecca

“…There is a paucity of published health-related quality of life (HRQOL) outcomes in patients with oligometastatic disease (OMD) who receive stereotactic body…”
Get full text

Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position by Jones, Christopher M., Radhakrishna, Ganesh, Aitken, Katharine, Bridgewater, John, Corrie, Pippa, Eatock, Martin, Goody, Rebecca, Ghaneh, Paula, Good, James, Grose, Derek, Holyoake, Daniel, Hunt, Arabella, Jamieson, Nigel B., Palmer, Daniel H., Soonawalla, Zahir, Valle, Juan W., Hawkins, Maria A., Mukherjee, Somnath

“…The coronavirus disease 2019 (COVID-19) pandemic epicentre has moved to the USA and Europe, where it is placing unprecedented demands on healthcare resources…”
Get full text

PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development by Grose, Derek B., Jamieson, Nigel Balfour, Radhakrishna, Ganesh, Hawkins, Maria A., McIntosh, David, Duffton, Aileen, Graham, Janet Shirley, Goody, Rebecca, Houston, Peter, Bradley, Sarah, Ravikumar, Reena, Christie, Alan, Dixon-Hughes, Judith, Kelly, Caroline, Paterson, Lucy, Biankin, Andrew V., McKay, Colin J., Chang, David Kuang-Fu

“…669 Background: There is increasing evidence suggesting benefit from a neoadjuvant approach to PC. However, the optimal regimen is unclear and will likely…”
Get full text

Hypofractionated radiotherapy to the pancreas: U.K. experience by Teoh, Suliana, Sabbagh, Ahmad, Wadsley, Jonathan, Low, Lori, Harrison, Claire, O'Hare, Jolyne, Goody, Rebecca, Summers, Kitty, Wilson, David, Walther, Julie, Wilson, Fiona, Radhakrishna, Ganesh, Aitken, Katharine, Owens, Rob, Mukherjee, Somnath

“…Abstract only 525 Background: During the COVID19 pandemic, many centres in the UK, shifted towards utilising hypofractionated radiotherapy (RT) to pancreas. We…”
Get full text

Palliative radiotherapy to the oesophagus: Less is just as good by Parikh, Shefali Pradeep, Goody, Rebecca, Coen, Oliver, Radhakrishna, Ganesh, Hatfield, Paul, Mohan, Hingorani

Get full text

Routine clinical experience using definitive carboplatin paclitaxel chemo-radiotherapy in oesophageal cancer by Parikh, Shefali Pradeep, Hingorani, Mohan, Mansell, Julie, Hatfield, Paul, Radhakrishna, Ganesh, Goody, Rebecca

Get full text

Experience of an image-guided radiotherapy (IGRT) training programme for clinical oncology trainees at Leeds Cancer Centre by Slevin, Finbar, Boon, Ian, Picken, Kelly, Jackson, Laura, Goody, Rebecca, Dickinson, Peter, Prestwich, Robin, Franks, Kevin, Clarke, Katy

Get full text

Reply to Comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic” by Jones, Christopher M., Radhakrishna, Ganesh, Aitken, Katharine, Bridgewater, John, Corrie, Pippa, Eatock, Martin, Goody, Rebecca, Ghaneh, Paula, Good, James, Grose, Derek, Holyoake, Daniel, Hunt, Arabella, Jamieson, Nigel B., Palmer, Daniel H., Soonawalla, Zahir, Valle, Juan W., Hawkins, Maria A., Mukherjee, Somnath

Get full text

PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab -paclitaxel (FA) and nab -paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development by Grose, Derek B., McKay, Colin J, Cooke, Susie, Graham, Janet Shirley, Duthie, Fraser, Jamieson, Nigel, Ravikumar, Reena, Duffton, Aileen, McIntosh, David, Goody, Rebecca, Radhakrishna, Ganesh, Hawkins, Maria A, Colville, Dave, Willshire, Christine, Stobo, Jon, Paul, James, Bradley, Sarah, Dixon-Hughes, Judith, Biankin, Andrew Victor, Chang, David Kuang-Fu

“…Abstract only TPS4166 Background: There is increasing evidence suggesting benefit from a neoadjuvant approach to PC. However, the optimal regimen is unclear…”
Get full text

Small cell cancer of the oesophagus – a network series by Martin, Amy, Murray, Louise, Murray, Patrick, Goody, Rebecca, Hatfield, Paul, Crellin, Adrian, Scott, Nigel, Fosker, Christopher, Ramasamy, Satiavani, Radhakrishna, Ganesh

Get full text